With 0.14 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.16 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $2.43 whereas the lowest price it dropped to was $2.29. The 52-week range on PHLT shows that it touched its highest point at $4.35 and its lowest point at $2.32 during that stretch. It currently has a 1-year price target of $7.00. Beta for the stock currently stands at 0.10.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PHLT was down-trending over the past week, with a drop of -8.33%, but this was down by -37.23% over a month. Three-month performance dropped to -40.00% while six-month performance fell -23.00%. The stock lost -13.81% in the past year, while it has lost -23.51% so far this year. A look at the trailing 12-month EPS for PHLT yields -0.11 with Next year EPS estimates of -0.01. For the next quarter, that number is 0.00. This implies an EPS growth rate of -33.33% for this year and 90.00% for next year.
Float and Shares Shorts:
At present, 78.29 million PHLT shares are outstanding with a float of 69.38 million shares on hand for trading. On 2024-12-31, short shares totaled 1.07 million, which was 136.0 higher than short shares on 1731628800. In addition to Ms. Lisa C. Im as the firm’s Executive Chairman & Secretary, Mr. Simeon M. Kohl serves as its CEO & Director.
Institutional Ownership:
Through their ownership of 0.84325 of PHLT’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, PHLT reported revenue of $31519000.0 and operating income of -$2149000.0. The EBITDA in the recently reported quarter was -$41000.0 and diluted EPS was -$0.03.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With PHLT analysts setting a high price target of 8.0 and a low target of 6.0, the average target price over the next 12 months is 7.0. Based on these targets, PHLT could surge 246.32% to reach the target high and rise by 159.74% to reach the target low. Reaching the average price target will result in a growth of 203.03% from current levels.
Based on analyst estimates, the high estimate for the next quarter is -$0.02 and the low estimate is -$0.06. The average estimate for the next quarter is thus -$0.03.
